Skip to main content
. 2014 May 27;2(1):e11. doi: 10.2196/medinform.3037

Table 3.

Table 3. Summary of the sample sizes (number of reviews reporting nonzero values) for evaluating each of the expected manifestations.


DTA Treatment
DATAINC 13/13 186/195
DATAFT 12/13 133/195
DATASR 13/13 101/195
DATAINC / FT 12/13 126/195
DATAINC / SR 13/13 95/195
DATAFT / SR 12/13 92/195